Warby Parker
Warby Parker Inc is an American prescription eyewear brand operating a direct-to-consumer and retail network across North America. The company designs, markets, and sells prescription eyeglasses, contact lenses, sunglasses, and vision care products, alongside offering in-person eye exams and vision testing software. Principal revenues derive from direct retail sales of prescription eyewear and contact lenses through company-owned stores and digital e-commerce channels. Core end markets encompass prescription eyewear consumers, contact lens wearers, and retail vision care shoppers in the United States and Canada. Warby Parker holds an established position in the North American eyewear industry as a pioneer of direct-to-consumer retail and affordable prescription eyewear. The corporation is headquartered in New York, New York, and its Class A common stock trades on the New York Stock Exchange.
3 of the funds FundTelligence covers report a position in Warby Parker.
- Legal name
- Warby Parker Inc
- Sector
- Consumer Discretionary
- Country
- United States
- Funds holding it
- 3
Funds holding Warby Parker
- DNB Fund Disruptive Opportunities — DNB · 0.31 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)